H.C. Wainwright Starts Cell Therapeutics (CTIC) at Buy

November 4, 2013 7:34 AM EST Send to a Friend
Get Alerts CTIC Hot Sheet
Price: $2.44 +0.41%

Rating Summary:
    8 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 14 | Down: 28 | New: 51
Trade CTIC Now!
Join SI Premium – FREE
H.C. Wainwright initiates coverage on Cell Therapeutics (NASDAQ: CTIC) with a Buy. PT $4.00.

For an analyst ratings summary and ratings history on Cell Therapeutics click here. For more ratings news on Cell Therapeutics click here.

Shares of Cell Therapeutics closed at $1.63 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

New Coverage

Add Your Comment